Holen Sie sich die Stockscreener-App
89.96
0.43%
-0.39
Handel nachbörslich:
89.87
-0.09
-0.10%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$90.35
Offen:
$90.97
24-Stunden-Volumen:
3.68M
Relative Volume:
0.97
Marktkapitalisierung:
$43.74B
Einnahmen:
$6.13B
Nettoeinkommen (Verlust:
$272.21M
KGV:
162.94
EPS:
0.5521
Netto-Cashflow:
$1.38B
1W Leistung:
+3.94%
1M Leistung:
+5.41%
6M Leistung:
+15.33%
1J Leistung:
+41.14%
1-Tages-Spanne:
$89.90
$90.99
1-Wochen-Bereich:
$86.65
$90.99
52-Wochen-Spanne:
$61.76
$90.99
Ventas Inc Stock (VTR) Company Profile
Firmenname
Ventas Inc
Sektor
Telefon
(312) 660-3800
Adresse
300 N LASALLE STREET, CHICAGO, IL
Compare VTR vs WELL, OHI, DOC, CTRE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTR
Ventas Inc
|
89.96 | 43.93B | 6.13B | 272.21M | 1.38B | 0.5521 |
WELL
Welltower Inc
|
217.75 | 155.40B | 11.75B | 1.46B | 2.19B | -0.6014 |
OHI
Omega Healthcare Investors Inc
|
47.93 | 14.29B | 1.24B | 655.98M | 857.80M | 2.063 |
DOC
Healthpeak Properties Inc
|
19.56 | 13.48B | 2.87B | 250.10M | 1.13B | 0.3188 |
CTRE
Caretrust Reit Inc
|
41.93 | 10.03B | 522.75M | 333.94M | 397.14M | 1.5617 |
Ventas Inc Stock (VTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | Goldman | Buy |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-09-19 | Eingeleitet | UBS | Neutral |
| 2025-06-23 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-03-07 | Hochstufung | Argus | Hold → Buy |
| 2025-01-17 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-10-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-03-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-02-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-01-30 | Eingeleitet | Deutsche Bank | Buy |
| 2024-01-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-11-07 | Hochstufung | Wedbush | Neutral → Outperform |
| 2023-10-11 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-10-03 | Eingeleitet | Wedbush | Neutral |
| 2023-09-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-08-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-06-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-04-20 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-01 | Bestätigt | Credit Suisse | Outperform |
| 2022-11-01 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-10-10 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-06-30 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-23 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | CapitalOne | Overweight |
| 2022-05-18 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-03-11 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2022-03-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-20 | Hochstufung | Mizuho | Neutral → Buy |
| 2021-12-14 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-22 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2021-10-04 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-09-23 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-09-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-08-26 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-14 | Fortgesetzt | Mizuho | Neutral |
| 2021-06-15 | Eingeleitet | Wolfe Research | Outperform |
| 2021-06-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-05-13 | Hochstufung | KeyBanc Capital Markets | Underweight → Overweight |
| 2021-05-13 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-01-08 | Herabstufung | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-06 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-11-30 | Hochstufung | BofA Securities | Underperform → Buy |
| 2020-11-10 | Hochstufung | Jefferies | Underperform → Hold |
| 2020-09-08 | Herabstufung | Argus | Buy → Hold |
| 2020-09-02 | Fortgesetzt | Stifel | Hold |
| 2020-08-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2020-08-14 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2020-08-14 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-06-15 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-25 | Hochstufung | Raymond James | Mkt Perform → Strong Buy |
| 2020-03-23 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-03-10 | Herabstufung | Jefferies | Buy → Underperform |
| 2020-02-28 | Hochstufung | Raymond James | Underperform → Mkt Perform |
| 2020-01-22 | Herabstufung | Raymond James | Mkt Perform → Underperform |
| 2020-01-17 | Hochstufung | Jefferies | Hold → Buy |
| 2019-12-20 | Fortgesetzt | Mizuho | Neutral |
| 2019-12-10 | Herabstufung | Wells Fargo | Market Perform → Underperform |
| 2019-11-19 | Hochstufung | Argus | Hold → Buy |
| 2019-10-30 | Herabstufung | Stifel | Buy → Hold |
| 2019-10-28 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2019-10-28 | Herabstufung | Citigroup | Buy → Neutral |
Alle ansehen
Ventas Inc Aktie (VTR) Neueste Nachrichten
[144] Ventas, Inc. SEC Filing - Stock Titan
Ventyx Biosciences stock (US92276F1003): Acquired by Eli Lilly for $1.2B in January - AD HOC NEWS
Ventas stock (US92276F1003): Maintains $0.52 quarterly dividend - AD HOC NEWS
Ventas Inc To Go Ex-Dividend On June 30th, 2026 With 0.52 USD Dividend Per Share - 富途牛牛
Ventas declares $0.52 quarterly dividend per share - Investing.com
Ventas Keeps Quarterly Dividend at $0.52 a Share, Payable July 16 to Shareholders of Record on June 30 - marketscreener.com
Ventas Inc. stock outperforms competitors on strong trading day - MarketWatch
Ventas declares $0.52 quarterly dividend per share By Investing.com - Investing.com Canada
Ventas Declares Quarterly Dividend of $0.52 Per Common Share - The Joplin Globe
Ventas stock (US92276F1003): Jefferies lifts price target to $100 - AD HOC NEWS
Ventas stock (US92276F1003): Jefferies raises price target to $100 - AD HOC NEWS
Jefferies Adjusts Price Target on Ventas to $100 From $97, Maintains Buy Rating - marketscreener.com
Jefferies Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $100 - Moomoo
Earnings preview: What to expect from Ventas’ report - MSN
VTR PE Ratio & Valuation, Is VTR Overvalued - Intellectia AI
JPMorgan reports 33.87M VTR shares (NYSE: VTR) in 13G/A amendment - Stock Titan
Ventas stock (US92276F1003): Real estate investment trust focused on senior housing and healthcare - AD HOC NEWS
Ventas Inc stock hits all-time high at 88.52 USD By Investing.com - Investing.com Nigeria
Ventas Inc. buy JPMorgan Chase & Co. - sharewise.com
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Ventas (NYSE:VTR) Stock - MarketBeat
J.P. Morgan Maintains Ventas Inc(VTR.US) With Buy Rating, Raises Target Price to $94 - 富途牛牛
Ventas (VTR) Could Be a Great Choice - Yahoo Finance
What Are Wall Street Analysts' Target Price for Ventas Stock? - Yahoo Finance
Ventas Inc stock hits all-time high at 88.52 USD - Investing.com
JPMorgan Adjusts Price Target on Ventas to $94 From $93 - marketscreener.com
What's in the offing for Ventas stock this earnings season? - MSN
ABN AMRO Bank N.V. Decreases Stock Holdings in Ventas, Inc. $VTR - MarketBeat
VTR: VentasInteractive Chart - Zacks Investment Research
Baron Real Estate Income Fund's Ventas Inc(VTR) Holding History - GuruFocus
Ethic Inc. Increases Stake in Ventas, Inc. $VTR - MarketBeat
Promising Real Estate Stocks To Add to Your WatchlistMay 9th - MarketBeat
Ventas Inc. stock (US92276F1003): REIT raises dividend and beats Q1 2026 estimates on senior housing - AD HOC NEWS
2 retirement communities in Benton County sell for $41 million - Talk Business & Politics
Swedbank AB Increases Stock Position in Ventas, Inc. $VTR - MarketBeat
Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Position in Ventas, Inc. $VTR - MarketBeat
Free cash flow per share of Ventas, Inc. – MUN:VEN - TradingView
VTR Technical Analysis | Trend, Signals & Chart Patterns | VENTAS INC (NYSE:VTR) - ChartMill
Number of shareholders of Ventas, Inc. – NYSE:VTR - TradingView
Ventas boosts full-year earnings guidance as occupancy gains fuel Q1 earnings beat - MSN
KeyBanc Maintains Ventas Inc(VTR.US) With Buy Rating, Announces Target Price $95 - 富途牛牛
VTR SEC FilingsVentas 10-K, 10-Q, 8-K Forms - Stock Titan
JPMorgan Stake Highlights Ventas Valuation Debate And Senior Housing Outlook - Yahoo Finance
Indivisible Partners Makes New Investment in Ventas, Inc. $VTR - MarketBeat
M&T Bank Corp Grows Holdings in Ventas, Inc. $VTR - MarketBeat
Ventas VTR Q1 2026 Earnings Call Transcript - AOL.com
Ventas expects $3.86 FFO per share in 2026 as it raises investment plan to $3B - MSN
Ventas (VTR) EVP Bulgarelli has 6,214 RSU shares withheld for taxes - Stock Titan
Ventas Inc. stock outperforms competitors despite losses on the day - MarketWatch
Ventas Named a Founding Partner of Real Estate Executive Council’s Diversity Initiative - Nareit
Should Ventas’ (VTR) Upgraded 2026 Earnings Guidance Shift How Investors View Its Core REIT Strategy? - simplywall.st
Ventas (VTR) Receives a Buy from RBC Capital - The Globe and Mail
Finanzdaten der Ventas Inc-Aktie (VTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.15%
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):